Moderna Booster Shots Work Well Against Variants: Early Data
Moderna's booster shot for COVID variants shows promising effectiveness in protecting people against the South African COVID variant. Early data from Moderna's Phase 2 clinical trials show that a third dose increased levels of antibodies against the virus. The booster was administered eight months after the participants had been initially vaccinated, according to an NBC News report. "Our mRNA platform allows for rapid design of vaccine candidates that incorporate key virus mutations, potentially allowing for faster development of future alternative variant-matched vaccines should they be need...